Pharmaceutical Technology on MSN
Day one concludes Mersana Therapeutics acquisition
Day One Biopharmaceuticals has concluded its acquisition of Mersana Therapeutics after meeting all the tender offer ...
Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback